Insider · CIK 0001324991

Tyree James L

CIK 0001324991 Name as filed on the most recent filing

Filed as Tyree James L (29)

115 transaction lines · from 29 filings · filed 2006-02-22 to 2024-12-30 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

115 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-12-30 S, Open-market sale Genelux CorpGNLX 8,512, disposed Open Form 4 filing 0001415889-24-030248
2024-09-11 S, Open-market sale Genelux CorpGNLX 4,499, disposed Open Form 4 filing 0001415889-24-023335
2024-05-29 P, Open-market purchase Genelux CorpGNLX Not reported Open Form 4 filing 0001415889-24-016110
2024-03-14 S, Open-market sale Assertio Holdings, Inc.ASRT 11,463, disposed Open Form 4 filing 0001104659-24-035117
2023-12-13 S, Open-market sale Genelux CorpGNLX 2 lines 118,969, disposed Open Form 4 filing 0001209191-23-058710
2023-05-05 S, Open-market sale Assertio Holdings, Inc.ASRT 258,767, disposed Open Form 4 filing 0001808665-23-000020
2022-08-04 S, Open-market sale ChemoCentryx, Inc.CCXI 502,200, disposed Open Form 4 filing 0001209191-22-044891
2022-06-09 S, Open-market sale ChemoCentryx, Inc.CCXI 2 lines 99,129, disposed Open Form 4 filing 0001209191-22-036438
2022-05-12 S, Open-market sale Assertio Holdings, Inc.ASRT 105,170, disposed Open Form 4 filing 0001808665-22-000039
2021-12-17 S, Open-market sale ChemoCentryx, Inc.CCXI 3 lines 1,313,165, disposed Open Form 4 filing 0001209191-21-070839
2021-05-21 S, Open-market sale ChemoCentryx, Inc.CCXI 23,956, disposed Open Form 4 filing 0001209191-21-035562
2020-01-13 S, Open-market sale ChemoCentryx, Inc.CCXI 2 lines 1,111,686, disposed Open Form 4 filing 0001209191-20-003510
2016-05-23 S, Open-market sale ChemoCentryx, Inc.CCXI 24,337, disposed Open Form 4 filing 0001209191-16-123070
2016-05-18 S, Open-market sale Innoviva, Inc.INVA 8,512, disposed Open Form 4 filing 0001179110-16-025263
2015-06-02 S, Open-market sale Theravance IncTHRX 41,080, disposed Open Form 4 filing 0001179110-15-009156
2015-05-22 S, Open-market sale ChemoCentryx, Inc.CCXI 94,593, disposed Open Form 4 filing 0001209191-15-046804
2009-02-27 S, Open-market sale Abbott LaboratoriesABT 9 lines 498,458, disposed Open Form 4 filing 0001104659-09-013946
2009-02-17 S, Open-market sale Abbott LaboratoriesABT 2 lines 301,030, disposed Open Form 4 filing 0001104659-09-010665
2009-02-02 S, Open-market sale Abbott LaboratoriesABT 15 lines 1,858,902, disposed Open Form 4 filing 0001104659-09-010511
2009-02-02 S, Open-market sale Abbott LaboratoriesABT 3,028,879, disposed Open Form 4 filing 0001104659-09-006508
2009-02-02 S, Open-market sale Abbott LaboratoriesABT 293,249, disposed Open Form 4 filing 0001104659-09-006508
2009-02-02 S, Open-market sale Abbott LaboratoriesABT 265,008, disposed Open Form 4 filing 0001104659-09-006508

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 1
  • Open-market sale 114
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Tyree James L, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001324991

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.